Kidney Transplant Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

Kidney Transplant Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

 

Global Kidney Transplant Market: By Application (Drug Delivery, Capsule Endoscopy, Patient Monitoring), By Target Area (Stomach, Esophagus, Large Intestine, Small Intestine), By End User (Hospitals, Clinics, Research Institutes), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

Global kidney transplant market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024.

 

Market Outline: Kidney Transplant Market

Kidney transplant or renal transplant is transplantation of kidney to the end-stage renal disease (ESRD). Based on the donor kidney transplantation is classified into deceased donor or living donor transplantation. Kidney transplant gained widespread popularity by improving outcome of ESRD patients.

 

Market Dynamics: Kidney Transplant Market

Kidney transplant market is witnessed to grow at a significant CAGR owing to advancements in the kidney transplantation methods and increase in success rate of kidney transplants. Moreover, rise in prevalence of end stage renal disease (ESRD), increase in the number of deceased kidney donors, and sophisticated healthcare infrastructure are anticipated to fuel the kidney transplant market over the forecast years. However, high cost of kidney transplant procedure and adverse effects associated with organ transplantation are expected to restrain the growth of kidney transplant market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/kidney-transplant-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Kidney Transplant Market

Kidney transplant market is segmented on the basis of immunosuppressive/rejection drugs and distribution channel

Based on the immunosuppressive/rejection drugs kidney transplant market is segmented into the following:

  • Prograf (Tacrolimus)
  • Myfortic (Mycophenolic Acid)
  • Cellcept (Mycophenolate Mofetil)
  • Zortress / Certican (Everolimus)
  • Rapamune (Sirolimus)
  • Neoral / Sandimmune (Cyclosporine)

Based on the distribution channel, kidney transplant market is segmented into the following:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Stores

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/kidney-transplant-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Kidney Transplant Market

Geographically, global kidney transplant market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America kidney transplant market is expected to expand at significant CAGR due to increase in prevalence of ESRD, rise in healthcare expenditure, and well established healthcare infrastructure. Europe kidney transplant market is anticipated to increase revenue share owing to increase in awareness about organ donation, favorable reimbursement policies for organ transplantation, and adoption of newer organ transplantation procedures. Asia pacific kidney transplant market is projected to provide enormous growth opportunities to the market players. Increased medical tourism in Asia Pacific countries, large patient pool, and government programs to enhance awareness about the organ donations are expected to bolster the market over the forecast years.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/kidney-transplant-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Kidney Transplant Market

Some of the players in the global kidney transplant market include:

  • Veloxis Pharmaceuticals A/S (Denmark)
  • Sanofi (France)
  • Immucor, Inc. (U.S)
  • Biocon Ltd. (India)
  • Novartis AG (Switzerland)
  • Pfizer, Inc. (U.S.)
  • Astellas Pharma (U.S.)
  • Hoffmann La Roche Ltd. (Switzerland)

 

Notable Market Developments: Kidney Transplant Market

  • In April 2017, Sanofi received FDA approval of Thymoglobulin used in preventiuon of acute kidney transplant rejection

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/kidney-transplant-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com